Shots:
- A consortium led by CVC and GBL launched a voluntary cash tender offer to acquire Recordati at €51.29/share, valuing the transaction at ~€10.7B (~$12.4B). The offer aims to delist Recordati from Euronext Milan & is expected to close in Q4’26
- The offer is backed by Rossini, which agreed to tender its 97.9M shares (~46.8% stake) in Recordati. Additional investors participating alongside CVC & GBL incl. ADIA, CPP Investments, PSP Investments, StepStone, AlpInvest, CapSol, MGG Strategic, & Andrea Recordati
- The proposed private ownership structure aims to support Recordati’s next growth phase through rare disease expansion, strategic acquisitions, increased R&D investment, & long-term global development
Ref: Recordati | Image: Recordati | Press Release
Related News: CVC Capital Partners Proposes ~€10.9B Acquisition of Recordati
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
